{"id":"doi:10.1002/oby.22794","kind":"article","title":"Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5","authors":["Robert F. Kushner","Salvatore Calanna","Melanie Jane Davies","Dror Dicker","William Timothy Garvey","Bryan Goldman","Ildiko Lingvay","Mette Thomsen","Thomas A. Wadden","Sean Wharton","John P.H. Wilding","Domenica Rubino"],"author_count":12,"year":2020,"published":"2020-05-22","venue":"Obesity","cited_by":288,"doi":"10.1002/oby.22794","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1002/oby.22794","archive_url":"https://space-kitty.com/papers/doi:10.1002/oby.22794","updated":null,"pmid":"32441473","pmcid":null,"openalex_id":"W3028216699","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/oby.22794","abstract":null,"abstract_license":null,"license":"cc-by-nc","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}